{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:51:59Z","timestamp":1791229919750,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clml.2020.12.005","type":"journal-article","created":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T12:04:33Z","timestamp":1607861073000},"page":"e272-e276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Breast Implant-associated Anaplastic Large Cell Lymphoma"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8134-8644","authenticated-orcid":false,"given":"Shaikha","family":"Alotaibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2919-4924","authenticated-orcid":false,"given":"Mubarak","family":"Al-Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.12.005_bib1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PRS.0000000000003233","article-title":"Global adverse event reports of breast implant-associated ALCL: an international review of 40 government authority databases","volume":"139","author":"Srinivasa","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/M15-1169","article-title":"Long-term health outcomes in women with silicone gel breast implants: a systematic review","volume":"164","author":"Balk","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clml.2020.12.005_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00266-016-0666-1","article-title":"Poly implant prothese and rofil substandard breast implant explantations from a large German single centre from 2011 to 2014: a comparative study","volume":"40","author":"Billner","year":"2016","journal-title":"Aesthet Plast Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006534-199708000-00065","article-title":"Anaplastic T-cell lymphoma in proximity to a saline- filled breast implant","volume":"100","author":"Keech","year":"1997","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neo-plasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.12.005_bib9","doi-asserted-by":"crossref","first-page":"30S","DOI":"10.1097\/PRS.0000000000005567","article-title":"Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants","volume":"143","author":"Collett","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoncol.2017.4510","article-title":"Breast implants and the risk of anaplastic large-cell lymphoma in the breast","volume":"4","author":"de Boer","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clml.2020.12.005_bib11","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/jama.2008.585","article-title":"Anaplastic large-cell lymphoma in women with breast implants","volume":"300","author":"de Jong","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.clml.2020.12.005_bib12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/PRS.0000000000001033","article-title":"Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases","volume":"135","author":"Brody","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib13","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1158\/1055-9965.EPI-13-0633","article-title":"Breast implants and anaplastic large-cell lymphoma: a Danish population-based cohort study","volume":"22","author":"Vase","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clml.2020.12.005_bib15","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1097\/PRS.0000000000005571","article-title":"Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): initial report of findings, 2012-2018","volume":"143","author":"McCarthy","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib16","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/PRS.0000000000003282","article-title":"U.S. Epidemiology of breast implant-associated anaplastic large cell lymphoma","volume":"139","author":"Doren","year":"2017","journal-title":"Plastic Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib17","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.3324\/haematol.2016.146118","article-title":"Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma","volume":"101","author":"Blombery","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.12.005_bib18","doi-asserted-by":"crossref","first-page":"766e","DOI":"10.1097\/01.prs.0000480003.80422.03","article-title":"The case against biofilm as the primary initiator of breast implant-associated anaplastic large cell lymphoma","volume":"137","author":"Brody","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib19","first-page":"26","article-title":"Anaplastic large cell lymphoma in the setting of textured breast implant: a call for patients and physicians education","volume":"165","author":"Zakhary","year":"2013","journal-title":"J\u00a0La State Med Soc"},{"key":"10.1016\/j.clml.2020.12.005_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/PRS.0b013e3182958a6d","article-title":"Subglandular breast augmentation with textured, anatomic, cohesive silicone implants: a review of 440 consecutive patients","volume":"132","author":"Lista","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2017-12-821868","article-title":"Genetic subtyping of breast implant-associated anaplastic large cell lymphoma","volume":"132","author":"Oishi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.12.005_bib22","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/PRS.0000000000002010","article-title":"Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma","volume":"137","author":"Hu","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib23","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/PRS.0000000000002170","article-title":"Discussion: bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma","volume":"137","author":"Adams","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib24","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1158\/1078-0432.CCR-12-0101","article-title":"Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphoma","volume":"18","author":"Lechner","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2020.12.005_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/PRS.0000000000003654","article-title":"Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are as- sociated with increased risk","volume":"140","author":"Loch-Wilkinson","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant- associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.12.005_bib27","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jamasurg.2017.4026","article-title":"Breast implant-associated anaplastic large cell lymphoma: a systematic review","volume":"152","author":"Leberfinger","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.clbc.2013.08.009","article-title":"Implant- associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules","volume":"13","author":"Bautista-Quach","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clml.2020.12.005_bib29","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1182\/blood.V88.8.3124.bloodjournal8883124","article-title":"Primary effusion lymphoma in women: report of two cases of Kaposi\u2019s sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women","volume":"88","author":"Said","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.12.005_bib30","doi-asserted-by":"crossref","first-page":"670e","DOI":"10.1097\/PRS.0000000000000535","article-title":"Large B-cell lymphoma occurring in a breast implant capsule","volume":"134","author":"Smith","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib31","doi-asserted-by":"crossref","first-page":"e1148","DOI":"10.1097\/GOX.0000000000001148","article-title":"New B-cell lymphomas in the setting of a previous rare breast implant-associated b-cell lymphoma","volume":"4","author":"Messer","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1016\/j.clml.2020.12.005_bib32","doi-asserted-by":"crossref","first-page":"NP52","DOI":"10.1093\/asj\/sjy093","article-title":"Breast implant-associated bilateral B-cell lymphoma","volume":"40","author":"Chen","year":"2020","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.clml.2020.12.005_bib33","first-page":"2004","article-title":"EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas","volume":"135","author":"Mescam","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.12.005_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAI.0b013e318266476c","article-title":"Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases","volume":"21","author":"Taylor","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.clml.2020.12.005_bib35","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/asj\/sjx040","article-title":"Commentary on: CD30+ T cells in late seroma may not be diagnostic of breast implant-associated anaplastic large cell lymphoma","volume":"37","author":"Clemens","year":"2017","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.clml.2020.12.005_bib36","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.12.005_bib37","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.12.005_bib38","series-title":"TNM Classification of Malignant Tumours","author":"Sobin","year":"2009"},{"key":"10.1016\/j.clml.2020.12.005_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/asj\/sjw259","article-title":"NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma","volume":"37","author":"Clemens","year":"2017","journal-title":"Aesthet Surg J"},{"issue":"Suppl_1","key":"10.1016\/j.clml.2020.12.005_bib40","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/asj\/sjy331","article-title":"2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)","volume":"39","author":"Clemens","year":"2019","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.clml.2020.12.005_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fonc.2015.00026","article-title":"Locally advanced breast implant-associated anaplastic large-cell lymphoma: a case report of successful treatment with radiation and chemotherapy","volume":"5","author":"Estes","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.clml.2020.12.005_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/2040620712443076","article-title":"Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma","volume":"3","author":"Vaklavas","year":"2012","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.clml.2020.12.005_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.critrevonc.2016.04.019","article-title":"Brentuximab vedotin in relapsed\/refractory Hodgkin lymphoma: an updated review of published data from the named patient program","volume":"104","author":"Zinzani","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clml.2020.12.005_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2020.12.005_bib45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bjps.2019.11.064","article-title":"Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants","volume":"73","author":"Cordeiro","year":"2020","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib46","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/PRS.0000000000005500","article-title":"The epidemiology of breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants","volume":"143","author":"Magnusson","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/PRS.0000000000001037","article-title":"Breast implant-associated anaplastic large cell lymphoma: a systematic review","volume":"135","author":"Gidengil","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2020.12.005_bib48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients","volume":"32","author":"Miranda","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.12.005_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-3034-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients","volume":"147","author":"Adrada","year":"2014","journal-title":"Breast Cancer Res Treat"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020306728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020306728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T06:36:38Z","timestamp":1730529398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020306728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2152265020306728"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.12.005","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast Implant-associated Anaplastic Large Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}